(Q33365152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

0 references

1 reference

title

Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Richard A. Hansen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Bradley N. Gaynes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Erin E Krebs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

7

Kathleen N Lohr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Patricia Thieda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Angela Deveaugh-Geiss

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

851-865

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-200831100-00004

13 January 2020

exact match

0 references

cites work

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831100-00004

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831100-00004

Better reporting of harms in randomized trials: an extension of the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831100-00004

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831100-00004

Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients

21 January 2018

2 references

https://api.crossref.org/works/10.2165%2F00002018-200831100-00004

21 January 2018

12 December 2020

A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo in Outpatients with Major Depression

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831100-00004

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831100-00004

Antidepressants and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831100-00004

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831100-00004

Double-blind comparison of bupropion and fluoxetine in depressed outpatients

21 January 2018

1 reference

12 December 2020

Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison

1 reference

12 December 2020

The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia

1 reference

12 December 2020

Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine

1 reference

12 December 2020

Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France

1 reference

12 December 2020

Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia

1 reference

12 December 2020

Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.

1 reference

12 December 2020

A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients

1 reference

12 December 2020

A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients

1 reference

12 December 2020

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

1 reference

12 December 2020

Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.

1 reference

12 December 2020

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial

1 reference

12 December 2020

Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms

1 reference

12 December 2020

Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction

1 reference

12 December 2020

Newer antidepressants: a comparison of tolerability in general practice

1 reference

12 December 2020

Network meta-analysis for indirect treatment comparisons

1 reference

12 December 2020

Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data

1 reference

12 December 2020

Antidepressants and the risk of suicidal behaviors

1 reference

12 December 2020

Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice

1 reference

12 December 2020

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

1 reference

12 December 2020

Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients

1 reference

12 December 2020

Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat).

1 reference

12 December 2020

A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies

1 reference

12 December 2020

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

1 reference

12 December 2020

A comparison of venlafaxine, trazodone, and placebo in major depression.

1 reference

12 December 2020

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

1 reference

12 December 2020

Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.

1 reference

12 December 2020

Mirtazapine compared with paroxetine in major depression

1 reference

12 December 2020

A comparative trial of fluoxetine versus trazodone in outpatients with major depression

1 reference

12 December 2020

A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients

1 reference

12 December 2020

A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.

1 reference

12 December 2020

Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit

1 reference

12 December 2020

A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression

1 reference

12 December 2020

Current methods of the US Preventive Services Task Force: a review of the process

1 reference

12 December 2020

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder

1 reference

12 December 2020

A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression

1 reference

12 December 2020

A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression

1 reference

12 December 2020

A 102-center prospective study of seizure in association with bupropion

1 reference

12 December 2020

Comparison of bupropion and trazodone for the treatment of major depression.

1 reference

12 December 2020

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

1 reference

12 December 2020

Escitalopram in the treatment of depressed elderly patients

1 reference

12 December 2020

Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.

1 reference

12 December 2020

Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety

1 reference

12 December 2020

A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice.

1 reference

12 December 2020

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study

1 reference

12 December 2020

Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial

1 reference

12 December 2020

1 reference

12 December 2020

Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports

1 reference

12 December 2020

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

1 reference

12 December 2020

Evaluating non-randomised intervention studies

1 reference

12 December 2020

A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression

1 reference

12 December 2020

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

1 reference

12 December 2020

A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.

1 reference

12 December 2020

Adverse events in users of sertraline: results from an observational study in psychiatric practice in The Netherlands

1 reference

12 December 2020

Antidepressants and the risk of falls among nursing home residents

1 reference

12 December 2020

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features

1 reference

12 December 2020

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.

1 reference

12 December 2020

Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction

1 reference

12 December 2020

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study

1 reference

12 December 2020

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

1 reference

12 December 2020

Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.

1 reference

12 December 2020

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients

1 reference

12 December 2020

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly

1 reference

12 December 2020

Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care

1 reference

12 December 2020

A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression

1 reference

12 December 2020

Prevalence of sexual dysfunction among newer antidepressants.

1 reference

12 December 2020

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression

1 reference

12 December 2020

Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

1 reference

12 December 2020

Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram

1 reference

12 December 2020

Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.

1 reference

12 December 2020

Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group

1 reference

12 December 2020

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group

1 reference

12 December 2020

Hepatic adverse reactions associated with nefazodone

1 reference

12 December 2020

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

1 reference

12 December 2020

Fluoxetine versus trazodone: efficacy and activating-sedating effects

1 reference

12 December 2020

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

1 reference

12 December 2020

A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression.

1 reference

12 December 2020

A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients

1 reference

12 December 2020

Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study

1 reference

12 December 2020

A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.

1 reference

12 December 2020

Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports

1 reference

12 December 2020

A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.

1 reference

12 December 2020

Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline

1 reference

12 December 2020

A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

1 reference

12 December 2020

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients

1 reference

12 December 2020

Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy

1 reference

12 December 2020

Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.

1 reference

12 December 2020

Sexual function during bupropion or paroxetine treatment of major depressive disorder.

1 reference

12 December 2020

A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder

1 reference

12 December 2020

Antidepressants and the serotonin syndrome in general practice

1 reference

12 December 2020

Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment

1 reference

12 December 2020

Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.

1 reference

12 December 2020

Serotonin syndrome. Presentation of 2 cases and review of the literature

1 reference

12 December 2020

Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients.

1 reference

12 December 2020

Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression

1 reference

12 December 2020

A comparison of fluvoxamine and fluoxetine in the treatment of major depression

1 reference

12 December 2020

A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.

1 reference

12 December 2020

Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study

1 reference

12 December 2020

Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication.

1 reference

12 December 2020

A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone

1 reference

12 December 2020

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

1 reference

12 December 2020

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

1 reference

12 December 2020

A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability

1 reference

12 December 2020

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

1 reference

12 December 2020

Are all antidepressants really the same? The case of fluoxetine: a systematic review.

1 reference

12 December 2020

Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine

1 reference

12 December 2020

Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment

1 reference

12 December 2020

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

1 reference

12 December 2020

A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder

1 reference

12 December 2020

A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients

1 reference

12 December 2020

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.

1 reference

12 December 2020

10.2165/00002018-200831100-00004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18759509%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 January 2020

0 references

1 reference